These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22936361)

  • 21. Impedance cardiography (ICG) noninvasive hemodynamic monitoring provides an opportunity to deliver cost effective, quality care for patients with cardiovascular disorders.
    Pranulis MF
    J Cardiovasc Manag; 2000; 11(3):13-7. PubMed ID: 11067240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Point-of-care glucose testing in critically ill patients: visual logistics and a glycemic variability hypothesis.
    Kost GJ; Tran NK; Sifontes JR; Mecozzi DM; Louie RF; Abad VJ
    Crit Care Med; 2009 Oct; 37(10):2841-3. PubMed ID: 19865008
    [No Abstract]   [Full Text] [Related]  

  • 23. How accurate are currently used methods of determining glycemia in critically ill patients, and do they affect their clinical course?
    Chrousos G; Kaltsas G
    Crit Care Med; 2005 Dec; 33(12):2849-51. PubMed ID: 16352973
    [No Abstract]   [Full Text] [Related]  

  • 24. [Computer-based monitoring in the process of diagnosing and correcting hemodynamic disorders in the first few hours after open heart surgery].
    Abbakumov VV; Eremenko AA
    Anesteziol Reanimatol; 1981; (2):27-30. PubMed ID: 7270970
    [No Abstract]   [Full Text] [Related]  

  • 25. Portable microfluidic and smartphone-based devices for monitoring of cardiovascular diseases at the point of care.
    Hu J; Cui X; Gong Y; Xu X; Gao B; Wen T; Lu TJ; Xu F
    Biotechnol Adv; 2016; 34(3):305-20. PubMed ID: 26898179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Point-of-care glucose measurement systems should be used with great caution in critically ill intensive care unit patients.
    Hoedemaekers CW; Klein Gunnewiek JM; Van der Hoeven JG
    Crit Care Med; 2010 Jan; 38(1):339; author reply 339-40. PubMed ID: 20023498
    [No Abstract]   [Full Text] [Related]  

  • 27. Monitoring pulmonary artery pressure.
    Keckeisen M
    Crit Care Nurse; 1999 Dec; 19(6):88-91. PubMed ID: 10889609
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical data collection in the information era.
    Schenkman KA
    Pediatr Crit Care Med; 2007 Nov; 8(6):588-9. PubMed ID: 17989567
    [No Abstract]   [Full Text] [Related]  

  • 29. Invasive hemodynamic monitoring: applying advanced technologies.
    Headley JM
    Crit Care Nurs Q; 1998 Nov; 21(3):73-84. PubMed ID: 10646423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in monitoring cardiovascular signals. Contribution of nonlinear signal processing.
    Signorini MG; Ferrario M; Cerutti S; Magenes G
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():6568-71. PubMed ID: 22255844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Home telecare.
    Ruggiero C; Sacile R; Giacomini M
    J Telemed Telecare; 1999; 5(1):11-7. PubMed ID: 10505364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analytical interference. More than just a laboratory problem.
    Kazmierczak SC; Catrou PG
    Am J Clin Pathol; 2000 Jan; 113(1):9-11. PubMed ID: 10631852
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical implications of subcutaneous glucose monitoring in critically ill patients.
    Hamilton LA
    Crit Care Med; 2011 Apr; 39(4):883-4. PubMed ID: 21613834
    [No Abstract]   [Full Text] [Related]  

  • 34. Objective cardiovascular assessment in the neonatal intensive care unit.
    Dempsey EM; El-Khuffash AF
    Arch Dis Child Fetal Neonatal Ed; 2018 Jan; 103(1):F72-F77. PubMed ID: 29127152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Could susceptibility to low hematocrit interference have compromised the results of the NICE-SUGAR trial?
    Cembrowski GS; Tran DV; Slater-Maclean L; Chin D; Gibney RT; Jacka M
    Clin Chem; 2010 Jul; 56(7):1193-5. PubMed ID: 20431051
    [No Abstract]   [Full Text] [Related]  

  • 36. [Autonomous monitoring of the complex array of parameters of the cardiovascular system].
    Aldonin GM
    Med Tekh; 2012; (6):14-7. PubMed ID: 23304985
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of the Accutrend Plus point-of-care monitor for blood triglyceride measurement in horses.
    Naylor RJ; Durward-Akhurst SA
    Vet Rec; 2012 Mar; 170(9):228. PubMed ID: 22351794
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessment of cardiac output (CO) is the holy grail of hemodynamic monitoring for the critically ill patient.
    Xu J; Yu Y; Walline J; Zhu H; Wang Z; Yu X
    J Trauma; 2009 Jun; 66(6):1747-8. PubMed ID: 19509644
    [No Abstract]   [Full Text] [Related]  

  • 39. Repair a Swan-Ganz? Why not?
    Charest CL; Pandolfi R
    RN; 1981 Aug; 44(8):53-5. PubMed ID: 6910768
    [No Abstract]   [Full Text] [Related]  

  • 40. Critical care echocardiography and outcomes in the critically ill.
    Singh K; Mayo P
    Curr Opin Crit Care; 2018 Aug; 24(4):316-321. PubMed ID: 29877876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.